Ashita Debnath, PharmD, BCIDP รีทวีตแล้ว

EMBLAVEO: catchy name & innovative antibiotic
Enterobacterales-MBL-AVibactam-aztrEOnam
Aztreonam/avibactam is being developed on the rationale that
⚡️Aztreonam isn't hydrolyzed by MBL enzymes
⚡️Avibactam takes care of
serine β-lactamases, eg ESBL/AmpC , co-produced by MBL

Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟@ABsteward
Breaking news🔥 US FDA approves EMBLAVEO (aztreonam and avibactam) for complicated intra-abdominal infections (cIAI) in adult patients who have limited or no alternative options #idxposts
English

























